Cargando…
The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study
BACKGROUND: The tumour-stroma ratio (TSR) is recognized as a practical prognostic factor in colorectal cancer. However, TSR assessment generally utilizes surgical specimens. This study aims to investigate whether the TSR evaluated from preoperative biopsy specimens by a semi-automatic quantification...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235870/ https://www.ncbi.nlm.nih.gov/pubmed/34172021 http://dx.doi.org/10.1186/s12885-021-08516-x |
_version_ | 1783714418195955712 |
---|---|
author | Liang, Yanting Zhu, Yaxi Lin, Huan Zhang, Shenyan Li, Suyun Huang, Yanqi Liu, Chen Qu, Jinrong Liang, Changhong Zhao, Ke Li, Zhenhui Liu, Zaiyi |
author_facet | Liang, Yanting Zhu, Yaxi Lin, Huan Zhang, Shenyan Li, Suyun Huang, Yanqi Liu, Chen Qu, Jinrong Liang, Changhong Zhao, Ke Li, Zhenhui Liu, Zaiyi |
author_sort | Liang, Yanting |
collection | PubMed |
description | BACKGROUND: The tumour-stroma ratio (TSR) is recognized as a practical prognostic factor in colorectal cancer. However, TSR assessment generally utilizes surgical specimens. This study aims to investigate whether the TSR evaluated from preoperative biopsy specimens by a semi-automatic quantification method can predict the response after neoadjuvant chemoradiotherapy (nCRT) of patients with locally advanced rectal cancer (LARC). METHODS: A total of 248 consecutive patients diagnosed with LARC and treated with nCRT followed by resection were included. Haematoxylin and eosin (HE)-stained sections of biopsy specimens were collected, and the TSR was evaluated by a semi-automatic quantification method and was divided into three categories, using the cut-offs determined in the whole cohort to balance the proportion of patients in each category. The response to nCRT was evaluated on the primary tumour resection specimen by an expert pathologist using the four-tier tumour regression grade (TRG) system. RESULTS: The TSR can discriminate patients that are major-responders (TRG 0–1) from patients that are non-responders (TRG 2–3). Patients were divided into stroma-low (33.5%), stroma-intermediate (33.9%), and stroma-high (32.7%) groups using 56.3 and 72.8% as the cutoffs. In the stroma-low group, 58 (69.9%) patients were major-responders, and only 39 (48.1%) patients were considered major-responders in the stroma-high group (P = 0.018). Multivariate analysis showed that the TSR was the only pre-treatment predictor of response to nCRT (adjusted odds ratio 0.40, 95% confidence interval 0.21–0.76, P = 0.002). CONCLUSION: An elevated TSR in preoperative biopsy specimens is an independent predictor of nCRT response in LARC. This semi-automatic quantified TSR could be easily translated into routine pathologic assessment due to its reproducibility and reliability. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08516-x. |
format | Online Article Text |
id | pubmed-8235870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82358702021-06-28 The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study Liang, Yanting Zhu, Yaxi Lin, Huan Zhang, Shenyan Li, Suyun Huang, Yanqi Liu, Chen Qu, Jinrong Liang, Changhong Zhao, Ke Li, Zhenhui Liu, Zaiyi BMC Cancer Research BACKGROUND: The tumour-stroma ratio (TSR) is recognized as a practical prognostic factor in colorectal cancer. However, TSR assessment generally utilizes surgical specimens. This study aims to investigate whether the TSR evaluated from preoperative biopsy specimens by a semi-automatic quantification method can predict the response after neoadjuvant chemoradiotherapy (nCRT) of patients with locally advanced rectal cancer (LARC). METHODS: A total of 248 consecutive patients diagnosed with LARC and treated with nCRT followed by resection were included. Haematoxylin and eosin (HE)-stained sections of biopsy specimens were collected, and the TSR was evaluated by a semi-automatic quantification method and was divided into three categories, using the cut-offs determined in the whole cohort to balance the proportion of patients in each category. The response to nCRT was evaluated on the primary tumour resection specimen by an expert pathologist using the four-tier tumour regression grade (TRG) system. RESULTS: The TSR can discriminate patients that are major-responders (TRG 0–1) from patients that are non-responders (TRG 2–3). Patients were divided into stroma-low (33.5%), stroma-intermediate (33.9%), and stroma-high (32.7%) groups using 56.3 and 72.8% as the cutoffs. In the stroma-low group, 58 (69.9%) patients were major-responders, and only 39 (48.1%) patients were considered major-responders in the stroma-high group (P = 0.018). Multivariate analysis showed that the TSR was the only pre-treatment predictor of response to nCRT (adjusted odds ratio 0.40, 95% confidence interval 0.21–0.76, P = 0.002). CONCLUSION: An elevated TSR in preoperative biopsy specimens is an independent predictor of nCRT response in LARC. This semi-automatic quantified TSR could be easily translated into routine pathologic assessment due to its reproducibility and reliability. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08516-x. BioMed Central 2021-06-25 /pmc/articles/PMC8235870/ /pubmed/34172021 http://dx.doi.org/10.1186/s12885-021-08516-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Liang, Yanting Zhu, Yaxi Lin, Huan Zhang, Shenyan Li, Suyun Huang, Yanqi Liu, Chen Qu, Jinrong Liang, Changhong Zhao, Ke Li, Zhenhui Liu, Zaiyi The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study |
title | The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study |
title_full | The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study |
title_fullStr | The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study |
title_full_unstemmed | The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study |
title_short | The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study |
title_sort | value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235870/ https://www.ncbi.nlm.nih.gov/pubmed/34172021 http://dx.doi.org/10.1186/s12885-021-08516-x |
work_keys_str_mv | AT liangyanting thevalueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT zhuyaxi thevalueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT linhuan thevalueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT zhangshenyan thevalueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT lisuyun thevalueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT huangyanqi thevalueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT liuchen thevalueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT qujinrong thevalueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT liangchanghong thevalueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT zhaoke thevalueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT lizhenhui thevalueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT liuzaiyi thevalueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT liangyanting valueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT zhuyaxi valueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT linhuan valueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT zhangshenyan valueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT lisuyun valueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT huangyanqi valueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT liuchen valueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT qujinrong valueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT liangchanghong valueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT zhaoke valueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT lizhenhui valueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy AT liuzaiyi valueofthetumourstromaratioforpredictingneoadjuvantchemoradiotherapyresponseinlocallyadvancedrectalcanceracasecontrolstudy |